Portal de Periódicos da CAPES

Management of Pediatric Psoriasis

2012; Elsevier BV; Volume: 41; Issue: 1 Linguagem: Inglês

10.3928/00904481-20111209-08

1938-2359

Tina Bhutani, Faranak Kamangar, Kelly M. Cordoro,

Dermatology and Skin Diseases

CME ArticleManagement of Pediatric Psoriasis Tina Bhutani, MD, , , MD Faranak Kamangar, BSc, , and , BSc Kelly M. Cordoro, MD, , MD Tina Bhutani, MD , Faranak Kamangar, BSc , and Kelly M. Cordoro, MD Published OnlineDecember 09, 2011https://doi.org/10.3928/00904481-20111209-08Cited by:21View Full Text ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinkedInRedditEmail SectionsMore"Management of Pediatric Psoriasis." Pediatric Annals, 41(1), pp. e11–e171.Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol. 2005; 141(12):1537–1541.10.1001/archderm.141.12.1537 Crossref MedlineGoogle Scholar2.Christophers E. Psoriasis — epidemiology and clinical spectrum. Clin Exp Dermatol. 2001; 26(4):314–320.10.1046/j.1365-2230.2001.00832.x Crossref MedlineGoogle Scholar3.Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc. 2004; 9(2):136–139.10.1046/j.1087-0024.2003.09102.x Crossref MedlineGoogle Scholar4.Tollefson MM, Crowson CS, McEvoy MT, Maradit Kremers H. Incidence of psoriasis in children: a population-based study. J Am Acad Dermatol. 2010; 62(6):979–987.10.1016/j.jaad.2009.07.029 Crossref MedlineGoogle Scholar5.Raychaudhuri SP, Gross J. A comparative study of pediatric onset psoriasis with adult onset psoriasis. Pediatr Dermatol. 2000; 17(3):174–178.10.1046/j.1525-1470.2000.01746.x Crossref MedlineGoogle Scholar6.Rogers M. Childhood psoriasis. Curr Opin Pediatr. 2002; 14(4):404–409.10.1097/00008480-200208000-00008 Crossref MedlineGoogle Scholar7.Farber EM, Nall ML. The natural history of psoriasis in 5,600 patients. Dermatologica. 1974; 148(1):1–18.10.1159/000251595 Crossref MedlineGoogle Scholar8.Morris A, Rogers M, Fischer G, Williams K. Childhood psoriasis: a clinical review of 1,262 cases. Pediatr Dermatol. 2001; 18(3):188–198.10.1046/j.1525-1470.2001.018003188.x Crossref MedlineGoogle Scholar9.Burden AD. Management of psoriasis in childhood. Clin Exp Dermatol. 1999; 24(5):341–345.10.1046/j.1365-2230.1999.00497.x Crossref MedlineGoogle Scholar10.Cordoro KM. Management of childhood psoriasis. Adv Dermatol. 2008; 24:125–169.10.1016/j.yadr.2008.09.009 Crossref MedlineGoogle Scholar11.Telfer NR, Chalmers RJ, Whale K, Colman G. The role of streptococcal infection in the initiation of guttate psoriasis. Arch Dermatol. 1992; 128(1):39–42.10.1001/archderm.1992.01680110049004 Crossref MedlineGoogle Scholar12.Silverberg NB. Pediatric psoriasis: an update. Ther Clin Risk Manag. 2009; 5:849–856.10.2147/TCRM.S4908 Crossref MedlineGoogle Scholar13.Kimball AB, Gladman D, Gelfand JM, et al.National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol. 2008; 58(6):1031–1042.10.1016/j.jaad.2008.01.006 Crossref MedlineGoogle Scholar14.Rapp SR, Feldman SR, Exum ML, Fleischer AB, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999; 41(3 Pt 1):401–407.10.1016/S0190-9622(99)70112-X Crossref MedlineGoogle Scholar15.Augustin M, Glaeske G, Radtke MA, Christophers E, Reich K, Schafer I. Epidemiology and comorbidity of psoriasis in children. Br J Dermatol. 2010; 162(3):633–636.10.1111/j.1365-2133.2009.09593.x Crossref MedlineGoogle Scholar16.Gottlieb A, Korman NJ, Gordon KB, et al.Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol. 2008; 58(5):851–864.10.1016/j.jaad.2008.02.040 Crossref MedlineGoogle Scholar17.Stoll ML, Lio P, Sundel RP, Nigrovic PA. Comparison of Vancouver and International League of Associations for rheumatology classification criteria for juvenile psoriatic arthritis. Arthritis Rheum. 2008; 59(1):51–58.10.1002/art.23240 Crossref MedlineGoogle Scholar18.Mahoney A. The severity of pediatric psoriasis correlates with the risk of obesity: An international multicenter controlled assessment. Paper presented at: SID 2011; Abstract 215.2011. Google Scholar19.Feldman SR. Approaching psoriasis differently: patient-physician relationships, patient education and choosing the right topical vehicle. J Drugs Dermatol. 2010; 9(8):908–911. MedlineGoogle Scholar20.Leman J, Burden D. Psoriasis in children: a guide to its diagnosis and management. Paediatr Drugs. 2001; 3(9):673–680.10.2165/00128072-200103090-00005 Crossref MedlineGoogle Scholar21.Cornell RC, Stoughton RB. Correlation of the vasoconstriction assay and clinical activity in psoriasis. Arch Dermatol. 1985; 121(1):63–67.10.1001/archderm.1985.01660010067020 Crossref MedlineGoogle Scholar22.Maibach HI, Wester RC. Issues in measuring percutaneous absorption of topical corticosteroids. Int J Dermatol. 1992; 31Suppl 1:21–25.10.1111/j.1365-4362.1992.tb04008.x Crossref MedlineGoogle Scholar23.Hong E, Smith S, Fischer G. Evaluation of the atrophogenic potential of topical corticosteroids in pediatric dermatology patients. Pediatr Dermatol. 2011; 28(4):393–396.10.1111/j.1525-1470.2011.01445.x Crossref MedlineGoogle Scholar24.Koo JY. New developments in topical sequential therapy for psoriasis. Skin Therapy Lett. 2005; 10(9):1–4. MedlineGoogle Scholar25.Lebwohl M, Siskin SB, Epinette W, et al.A multicenter trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis. J Am Acad Dermatol. 1996; 35(2 Pt 1):268–269.10.1016/S0190-9622(96)90349-7 Crossref MedlineGoogle Scholar26.Darley CR, Cunliffe WJ, Green CM, Hutchinson PE, Klaber MR, Downes N. Safety and efficacy of calcipotriol ointment (Dovonex) in treating children with psoriasis vulgaris. Br J Dermatol. 1996; 135(3):390–393.10.1111/j.1365-2133.1996.tb01501.x Crossref MedlineGoogle Scholar27.Saggese G, Federico G, Battini R. Topical application of 1,25-dihydroxyvitamin D3 (calcitriol) is an effective and reliable therapy to cure skin lesions in psoriatic children. Eur J Pediatr. 1993; 152(5):389–392.10.1007/BF01955893 Crossref MedlineGoogle Scholar28.Zhu X, Wang B, Zhao G, et al.An investigator-masked comparison of the efficacy and safety of twice daily applications of calcitriol 3 microg/g ointment vs. calcipotriol 50 microg/g ointment in subjects with mild to moderate chronic plaque-type psoriasis. J Eur Acad Dermatol Venereol. 2007; 21(4):466–472. Crossref MedlineGoogle Scholar29.Cram DL. Psoriasis: treatment with a tar gel. Cutis. 1976; 17(6):1197–1198, 1202–1203. MedlineGoogle Scholar30.Farber EM, Nall L. Psoriasis. A review of recent advances in treatment. Drugs. 1984; 28(4):324–346.10.2165/00003495-198428040-00003 Crossref MedlineGoogle Scholar31.Lin AN, Moses K. Tar revisited. Int J Dermatol. 1985; 24(4):216–218.10.1111/j.1365-4362.1985.tb05436.x Crossref MedlineGoogle Scholar32.van Schooten FJ, Godschalk R. Coal tar therapy. Is it carcinogenic?Drug Saf. 1996; 15(6):374–377.10.2165/00002018-199615060-00002 Crossref MedlineGoogle Scholar33.Pittelkow MR, Perry HO, Muller SA, Maughan WZ, O'Brien PC. Skin cancer in patients with psoriasis treated with coal tar. A 25-year follow-up study. Arch Dermatol. 1981; 117(8):465–468.10.1001/archderm.1981.01650080019020 Crossref MedlineGoogle Scholar34.Pion IA, Koenig KL, Lim HW. Is dermatologic usage of coal tar carcinogenic? A review of the literaure. Dermatol Surg. 1995; 21(3):227–231.10.1111/j.1524-4725.1995.tb00158.x Crossref MedlineGoogle Scholar35.Esgleyes-Ribot T, Chandraratna RA, Lew-Kaya DA, Sefton J, Duvic M. Response of psoriasis to a new topical retinoid, AGN 190168. J Am Acad Dermatol. 1994; 30(4):581–590.10.1016/S0190-9622(94)70066-4 Crossref MedlineGoogle Scholar36.Marks R. Early clinical development of tazarotene. Br J Dermatol. 1996; 135Suppl 49:26–31.10.1111/j.1365-2133.1996.tb15663.x Crossref MedlineGoogle Scholar37.Lebwohl MG, Breneman DL, Goffe BS, et al.Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis. J Am Acad Dermatol. 1998; 39(4 Pt 1):590–596.10.1016/S0190-9622(98)70008-8 Crossref MedlineGoogle Scholar38.Bianchi L, Soda R, Diluvio L, Chimenti S. Tazarotene 0.1% gel for psoriasis of the fingernails and toenails: an open, prospective study. Br J Dermatol. 2003; 149(1):207–209.10.1046/j.1365-2133.2003.05392.x Crossref MedlineGoogle Scholar39.Diluvio L, Campione E, Paterno EJ, Mordenti C, El Hachem M, Chimenti S. Childhood nail psoriasis: a useful treatment with tazarotene 0.05%. Pediatr Dermatol. 2007; 24(3):332–333.10.1111/j.1525-1470.2007.00421.x Crossref MedlineGoogle Scholar40.Nghiem P, Pearson G, Langley RG. Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis. J Am Acad Dermatol. 2002; 46(2):228–241.10.1067/mjd.2002.120942 Crossref MedlineGoogle Scholar41.Reichert U, Jacques Y, Grangeret M, Schmidt R. Antirespiratory and antiproliferative activity of anthralin in cultured human keratinocytes. J Invest Dermatol. 1985; 84(2):130–134.10.1111/1523-1747.ep12275369 Crossref MedlineGoogle Scholar42.Ashton RE, Andre P, Lowe NJ, Whitefield M. Anthralin: historical and current perspectives. J Am Acad Dermatol. 1983; 9(2):173–192.10.1016/S0190-9622(83)70125-8 Crossref MedlineGoogle Scholar43.Runne U, Kunze J. Short-duration ('minutes') therapy with dithranol for psoriasis: a new out-patient regimen. Br J Dermatol. 1982; 106(2):135–139.10.1111/j.1365-2133.1982.tb00922.x Crossref MedlineGoogle Scholar44.Zeichner JA, Lebwohl MG, Menter A, et al.Optimizing topical therapies for treating psoriasis: a consensus conference. Cutis. 2010; 86(3 Suppl):5–31; quiz 32. MedlineGoogle Scholar45.Diffey BL, Farr PM. The challenge of follow-up in narrowband ultraviolet B phototherapy. Br J Dermatol. 2007; 157(2):344–349.10.1111/j.1365-2133.2007.07980.x Crossref MedlineGoogle Scholar46.Wolff K. Side-effects of psoralen photoche-motherapy (PUVA). Br J Dermatol. 1990; 122Suppl 36:117–125.10.1111/j.1365-2133.1990.tb02889.x Crossref MedlineGoogle Scholar Previous article FiguresReferencesRelatedDetailsCited by Pope E, Deodhare N and Lara-Corrales I (2022) Neonate Dermatology Atlas of Dermatology, Dermatopathology and Venereology, 10.1007/978-3-319-53811-2_25, (585-633), . Kang B, O'Haver J and Andrews I (2021) Pediatric Psoriasis Comorbidities: Screening Recommendations for the Primary Care Provider, Journal of Pediatric Health Care, 10.1016/j.pedhc.2020.12.006, 35:3, (337-350), Online publication date: 1-May-2021. Cvenkel K and Starbek Zorko M (2021) Challenges in the treatment of psoriasis in childhood, Acta Dermatovenerologica Alpina Pannonica et Adriatica, 10.15570/actaapa.2021.26, 30:3, . Tolliver S, Pepper A, Pothiawala S and Silverberg N (2021) Pediatric Psoriasis Advances in Psoriasis, 10.1007/978-3-030-54859-9_25, (311-342), . Chu D and Cordoro K (2019) Psoriasis Harper's Textbook of Pediatric Dermatology, 10.1002/9781119142812.ch29, (354-361), Online publication date: 20-Nov-2019. Seyger M (2019) Psoriasis Harper's Textbook of Pediatric Dermatology, 10.1002/9781119142812.ch31, (368-375), Online publication date: 20-Nov-2019. Pope E, Deodhare N and Lara-Corrales I (2018) Neonate Dermatology Atlas of Dermatology, Dermatopathology and Venereology, 10.1007/978-3-319-45134-3_25-1, (1-49), . D'Adamio S, Silvaggio D, Massaro A, Lombardo P, Bianchi L, Talamonti M and Galluzzo M (2019) Pharmacotherapeutic management of psoriasis in adolescents and children, Expert Opinion on Pharmacotherapy, 10.1080/14656566.2019.1636032, 20:14, (1777-1785), Online publication date: 22-Sep-2019. Yang E, Sekhon S, Sanchez I, Beck K and Bhutani T (2018) Recent Developments in Atopic Dermatitis, Pediatrics, 10.1542/peds.2018-1102, 142:4, Online publication date: 1-Oct-2018. Eichenfield L, Paller A, Tom W, Sugarman J, Hebert A, Friedlander S, Siegfried E, Silverberg N and Cordoro K (2018) Pediatric psoriasis: Evolving perspectives, Pediatric Dermatology, 10.1111/pde.13382, 35:2, (170-181), Online publication date: 1-Mar-2018. Relvas M and Torres T (2017) Pediatric Psoriasis, American Journal of Clinical Dermatology, 10.1007/s40257-017-0294-9, 18:6, (797-811), Online publication date: 1-Dec-2017. Afsar F, Uysal S, Salis F and Calli A (2016) Napkin psoriasis, Pediatrics International, 10.1111/ped.12916, 58:5, (420-422), Online publication date: 1-May-2016. de Moll E, Chang M and Strober B (2016) Psoriasis in adults and children: Kids are not just little people, Clinics in Dermatology, 10.1016/j.clindermatol.2016.07.006, 34:6, (717-723), Online publication date: 1-Nov-2016. Bronckers I, Paller A, van Geel M, van de Kerkhof P and Seyger M (2015) Psoriasis in Children and Adolescents: Diagnosis, Management and Comorbidities, Pediatric Drugs, 10.1007/s40272-015-0137-1, 17:5, (373-384), Online publication date: 1-Oct-2015. Pacha O, Schlichte M and Hebert A (2014) Psoriasis and Pityriasis Rubra Pilaris Severe Skin Diseases in Children, 10.1007/978-3-642-39532-1_2, (21-35), . Pepper A, Pothiawala S and Silverberg N (2014) Pediatric Psoriasis Advances in Psoriasis, 10.1007/978-1-4471-4432-8_20, (253-276), . Shah K (2013) Diagnosis and Treatment of Pediatric Psoriasis: Current and Future, American Journal of Clinical Dermatology, 10.1007/s40257-013-0026-8, 14:3, (195-213), Online publication date: 1-Jun-2013. Díaz Gámez M and Martínez Castillo E (2017) psoriasis, Atención Familiar, 10.22201/facmed.14058871p.2017.2.59160, 24:2 Mhusakunchai P and Techasatian L (2021) An Association of Pediatric Psoriasis with Metabolic Syndrome in Thai Children: 20 Years Retrospective Study, Psoriasis: Targets and Therapy, 10.2147/PTT.S317593, Volume 11, (75-82) Rowawi R, Dwipangestu G, Suwarsa O, Dharmadji H, Sutedja E, Pangastuti M and Gunawan H (2020) A Successful Treatment of Ostraceous Psoriasis Associated with Psoriatic Arthritis in Children: A Case Report, Psoriasis: Targets and Therapy, 10.2147/PTT.S285832, Volume 10, (61-66) Kim H, Kang S, Kim J, Park C and Chung B (2021) Pediatric Psoriasis: From New Insights into Pathogenesis to Updates on Treatment, Biomedicines, 10.3390/biomedicines9080940, 9:8, (940) Request Permissions InformationCopyright 2012, SLACK IncorporatedAddress correspondence to: Kelly M. Cordoro, MD, University of California, San Francisco; fax: 415-353-7478; email: [email protected]ucsf.edu.Tina Bhutani, MD, is Clinical Research Fellow, UCSF Psoriasis and Skin Treatment Center, UCSF Department of Dermatology. Faranak Kamangar, BSc, is Clinical Research Associate, UCSF Psoriasis and Skin Treatment Center UCSF Department of Dermatology. Kelly M. Cordoro, MD, is Assistant Professor of Clinical Dermatology and Pediatrics, University of California, San Francisco.Dr. Bhutani and Ms. Kamangar have disclosed no relevant financial relationships. Dr. Cordoro has disclosed the following relevant financial relationships: consulting fees, Topaz Pharmaceuticals.